These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Nortriptyline capacity-limited metabolism: a case report. Browne JL; Perry PJ; Taylor JW; Sieleni BA; Kronfol Z J Clin Psychopharmacol; 1984 Dec; 4(6):322-5. PubMed ID: 6511999 [TBL] [Abstract][Full Text] [Related]
6. The contribution of pharmacokinetics to the best use of benzodiazepines and antidepressants. Gram LF Encephale; 1982; 8(2):291-8. PubMed ID: 6125380 [TBL] [Abstract][Full Text] [Related]
7. [Clinical pharmacokinetics of tricyclic antidepressants. Part I. Pharmacokinetic properties]. Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A Psychiatr Pol; 1993; 27(6):683-91. PubMed ID: 8134502 [TBL] [Abstract][Full Text] [Related]
9. The effect of nortriptyline in elderly patients with cardiac conduction disease. Dietch JT; Fine M J Clin Psychiatry; 1990 Feb; 51(2):65-7. PubMed ID: 2298706 [TBL] [Abstract][Full Text] [Related]
10. Extremely rapid hydroxylation of debrisoquine: a case report with implication for treatment with nortriptyline and other tricyclic antidepressants. Bertilsson L; Aberg-Wistedt A; Gustafsson LL; Nordin C Ther Drug Monit; 1985; 7(4):478-80. PubMed ID: 4082245 [No Abstract] [Full Text] [Related]
11. Plasma concentrations of tricyclic antidepressants in clinical practice. Hollister LE J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706 [TBL] [Abstract][Full Text] [Related]
12. Nortriptyline pharmacokinetic parameters in depressed children and adolescents: preliminary data. Geller B; Cooper TB; Chestnut E; Abel AS; Anker JA J Clin Psychopharmacol; 1984 Oct; 4(5):265-9. PubMed ID: 6490962 [TBL] [Abstract][Full Text] [Related]
13. [Clinical pharmacokinetics of tricyclic antidepressants Part II. Drug therapy monitoring]. Szymura-Oleksiak J; Wasieczko A; Wyska E; Zieba A Psychiatr Pol; 1994; 28(1):17-26. PubMed ID: 8190816 [TBL] [Abstract][Full Text] [Related]
14. Tricyclic antidepressants: clinical use of plasma levels. Preskorn SH; Madakasira S J Kans Med Soc; 1981 Mar; 82(3):122-4, 134. PubMed ID: 7276685 [No Abstract] [Full Text] [Related]
15. Tricyclic antidepressant plasma level monitoring: an improvement over the dose-response approach. Preskorn SH J Clin Psychiatry; 1986 Jan; 47(1 Suppl):24-30. PubMed ID: 2867088 [TBL] [Abstract][Full Text] [Related]
17. Maintenance nortriptyline effects on electroencephalographic sleep in elderly patients with recurrent major depression: double-blind, placebo- and plasma-level-controlled evaluation. Reynolds CF; Buysse DJ; Brunner DP; Begley AE; Dew MA; Hoch CC; Hall M; Houck PR; Mazumdar S; Perel JM; Kupfer DJ Biol Psychiatry; 1997 Oct; 42(7):560-7. PubMed ID: 9376452 [TBL] [Abstract][Full Text] [Related]
18. Rates of in vivo methylation of desipramine and nortriptyline. Kurpius MP; Alexander B Pharmacotherapy; 2006 Apr; 26(4):505-10. PubMed ID: 16553509 [TBL] [Abstract][Full Text] [Related]
19. Plasma level monitoring of antidepressants: theoretical basis and clinical application. Gram LF; Kragh-Sørensen P; Kristensen CB; Møller M; Pedersen OL; Thayssen P Adv Biochem Psychopharmacol; 1984; 39():399-411. PubMed ID: 6380231 [TBL] [Abstract][Full Text] [Related]
20. Prediction of individual dosage of nortriptyline in depressed elderly outpatients. Schneider LS; Cooper TB; Staples FR; Sloane RB J Clin Psychopharmacol; 1987 Oct; 7(5):311-4. PubMed ID: 3680600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]